BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35933296)

  • 21. HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant.
    Walton DC; Cantwell L; Hiho S; Ta J; Wright S; Sullivan LC; Snell GI; Westall GP
    Transpl Immunol; 2018 Dec; 51():73-75. PubMed ID: 30321645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Yacoub R; Nadkarni GN; Cravedi P; He JC; Delaney VB; Kent R; Chauhan KN; Coca SG; Florman SS; Heeger PS; Murphy B; Menon MC
    Kidney Int; 2018 Feb; 93(2):482-490. PubMed ID: 28965746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human leukocyte antigen, allele, and eplet mismatches in liver transplantation; observations from a small, single center cohort.
    Forner D; Liwski R; Alwayn I
    Hum Immunol; 2018 Mar; 79(3):154-159. PubMed ID: 29289739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations.
    Quantz MA; Bennett LE; Meyer DM; Novick RJ
    J Heart Lung Transplant; 2000 May; 19(5):473-9. PubMed ID: 10808155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of HLA eplet mismatch load in immunological outcomes after living donor kidney transplantation.
    Alves TA; Nascimento E; de Castro LB; Fabreti-Oliveira RA
    Transpl Immunol; 2023 Oct; 80():101908. PubMed ID: 37536379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of human leukocyte antigen donor-recipient matching and pediatric heart transplant graft survival.
    Butts RJ; Scheurer MA; Atz AM; Moussa O; Burnette AL; Hulsey TC; Savage AJ
    Circ Heart Fail; 2014 Jul; 7(4):605-11. PubMed ID: 24833649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary CXCL10 specifically relates to HLA-DQ eplet mismatch load in kidney transplant recipients.
    San Segundo D; Guiral-Foz SA; Benito-Hernández A; Fernández AR; Arnau A; Valero R; Ramos-Barrón MA; García-Unzueta MT; Gómez-Ortega JM; López-Hoyos M; Ruiz JC; Rodrigo E
    Transpl Immunol; 2022 Feb; 70():101494. PubMed ID: 34774739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
    Yanyiam P; Kantachuvesiri S; Thammanichanond D
    Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human leukocyte antigen eplet mismatches and long-term clinical outcomes in pediatric renal transplantation: A pragmatic, registry-based study.
    Sypek MP; Hiho S; Cantwell L; Clayton P; Hughes P; Le Page AK; Kausman J
    Pediatr Transplant; 2020 Jun; 24(4):e13705. PubMed ID: 32319719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of high-resolution HLA in the perioperative period of non-sensitized lung transplant recipients.
    Zhang J; Liu D; Zhang C; Zhou M; Lv J; Wang H; Yang H; Fan L; Wu B; Chen J
    Ann Transl Med; 2020 Feb; 8(3):37. PubMed ID: 32154282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
    Reindl-Schwaighofer R; Heinzel A; Kainz A; van Setten J; Jelencsics K; Hu K; Loza BL; Kammer M; Heinze G; Hruba P; Koňaříková A; Viklicky O; Boehmig GA; Eskandary F; Fischer G; Claas F; Tan JC; Albert TJ; Patel J; Keating B; Oberbauer R;
    Lancet; 2019 Mar; 393(10174):910-917. PubMed ID: 30773281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG
    Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human Leukocyte Antigen-Based Risk Stratification in Heart Transplant Recipients-Implications for Targeted Surveillance.
    Nilsson J; Ansari D; Ohlsson M; Höglund P; Liedberg AS; Smith JG; Nugues P; Andersson B
    J Am Heart Assoc; 2019 Aug; 8(15):e011124. PubMed ID: 31339067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of an epitope-based allocation system in pediatric kidney transplantation.
    Kausman JY; Walker AM; Cantwell LS; Quinlan C; Sypek MP; Ierino FL
    Pediatr Transplant; 2016 Nov; 20(7):931-938. PubMed ID: 27662811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
    Gavroy B; Timmermans T; Van Caenegem O; Mastrobuoni S; Jacquet L; Latinne D; Poncelet AJ
    Transpl Immunol; 2022 Dec; 75():101706. PubMed ID: 36113729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular-level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients - a retrospective study.
    Osorio-Jaramillo E; Haasnoot GW; Kaider A; Schaefer AK; Haberl T; Goekler J; Angleitner P; Moayedifar R; Zuckermann A; Fischer GF; Laufer G; Claas FHJ; Aliabadi-Zuckermann AZ
    Transpl Int; 2020 Sep; 33(9):1078-1088. PubMed ID: 32441827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
    J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.
    Firoz A; Geier S; Yanagida R; Hamad E; Rakita V; Zhao H; Kashem M; Toyoda Y
    J Card Fail; 2024 Feb; 30(2):362-372. PubMed ID: 37422273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.